Ausgabe 2/2019
Inhalt (22 Artikel)
Efficacy and safety of bevacizumab for vestibular schwannoma in neurofibromatosis type 2: a systematic review and meta-analysis of treatment outcomes
Victor M. Lu, Krishnan Ravindran, Christopher S. Graffeo, Avital Perry, Jamie J. Van Gompel, David J. Daniels, Michael J. Link
Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?
Charissa A. C. Jessurun, Alexander F. C. Hulsbergen, Logan D. Cho, Linda S. Aglio, Rishi D. S. Nandoe Tewarie, Marike L. D. Broekman
Absent in melanoma 2 regulates tumor cell proliferation in glioblastoma multiforme
P. A. Chen, G. Shrivastava, E. F. Balcom, B. A. McKenzie, J. Fernandes, W. G. Branton, B. M. Wheatley, K. Petruk, F. K. H. van Landeghem, Christopher Power
Comparison of ABC/2 estimation and a volumetric computerized method for measurement of meningiomas using magnetic resonance imaging
Charles F. Opalak, Matthew Parry, Andrew K. Rock, Adam P. Sima, Matthew T. Carr, Vyshak Chandra, Kathryn G. Workman, Aravind Somasundaram, William C. Broaddus
Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping
Tejpal Gupta, Madan Maitre, Goda Jayant Sastri, Rahul Krishnatry, Neelam Shirsat, Sridhar Epari, Ayushi Sahay, Girish Chinnaswamy, Vijay Patil, Prakash Shetty, Aliasgar Moiyadi
MPC1 deletion is associated with poor prognosis and temozolomide resistance in glioblastoma
Yi Chai, Caixia Wang, Wei Liu, Yanghua Fan, Yuqi Zhang
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)
John D. Hainsworth, Kevin P. Becker, Tarek Mekhail, Sajeel A. Chowdhary, Janice Faulkner Eakle, David Wright, Robert M. Langdon, Kathleen J. Yost, Gilbert Darin Anthony Padula, Kimberly West-Osterfield, Meredith Scarberry, Candice A. Shaifer, Mythili Shastry, Howard A. Burris III, Kent Shih
Between-hospital variation in mortality and survival after glioblastoma surgery in the Dutch Quality Registry for Neuro Surgery
Philip C. De Witt Hamer, Vincent K. Y. Ho, Aeilko H. Zwinderman, Linda Ackermans, Hilko Ardon, Sytske Boomstra, Wim Bouwknegt, Wimar A. van den Brink, Clemens M. Dirven, Niels A. van der Gaag, Olivier van der Veer, Albert J. S. Idema, Alfred Kloet, Jan Koopmans, Mark ter Laan, Marco J. T. Verstegen, Michiel Wagemakers, Pierre A. J. T. Robe
Single-fraction stereotactic radiosurgery for spindle cell oncocytoma: preliminary experience and systematic review of the literature
Soliman Oushy, Christopher S. Graffeo, Avital Perry, Scott L. Stafford, Michael J. Link, Bruce E. Pollock
Analysis of patterns of failure and appraisal of postoperative radiation field for grade II–III meningioma
Jason Joon Bock Lee, Jeongshim Lee, Hong In Yoon, Se Hoon Kim, Jaeho Cho, Kyu Sung Lee, Jong Hee Chang, Chang-Ok Suh
Fractionated stereotactic radiotherapy for local control of resected brain metastases
Jeffrey I. Traylor, Ahmed Habib, Rajan Patel, Matthew Muir, Ron Gadot, Tina Briere, Debra N. Yeboa, Jing Li, Ganesh Rao
A prospective evaluation of whole brain volume loss and neurocognitive decline following hippocampal-sparing prophylactic cranial irradiation for limited-stage small-cell lung cancer
Chengcheng Gui, Namrata Chintalapati, Russell Kenneth Hales, Khinh Ranh Voong, Haris Iqbal Sair, Jimm Grimm, Mario Duhon, Lawrence Richard Kleinberg, Tracy Dawn Vannorsdall, Kristin Janson Redmond
Phase II study of Dovitinib in recurrent glioblastoma
Mayur Sharma, Cathy Schilero, David M. Peereboom, Brian P. Hobbs, Paul Elson, Glen H. J. Stevens, Keith McCrae, Andrew B. Nixon, Manmeet S. Ahluwalia
Treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center
Ryan N. Nachwalter, Robert J. Rothrock, Evangelina Katsoulakis, Mrinal M. Gounder, Patrick J. Boland, Mark H. Bilsky, Ilya Laufer, Adam M. Schmitt, Yoshiya Yamada, Daniel S. Higginson
Multidimensional assessment of fatigue in patients with brain metastases before and after Gamma Knife radiosurgery
Eline Verhaak, Wietske C. M. Schimmel, Margriet M. Sitskoorn, Marjan Bakker, Patrick E. J. Hanssens, Karin Gehring
Cysts associated with intramedullary ependymomas of the spinal cord: clinical, MRI and oncological features
Corentin Dauleac, Rostom Messerer, Nathalie Obadia-Andre, Medhi Afathi, Cédric Y. Barrey
Stereotactic radiosurgery in elderly patients with brain metastases: comparison with non-elderly patients using database of a multi-institutional prospective observational study (JLGK0901-Elderly)
Yoshinori Higuchi, Masaaki Yamamoto, Toru Serizawa, Yasunori Sato, Takashi Shuto, Atsuya Akabane, Hidefumi Jokura, Shoji Yomo, Osamu Nagano, Jun Kawagishi, Kazuhiro Yamanaka, Hidefumi Aoyama
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma
Thomas J. Kaley, Katherine S. Panageas, Ingo K. Mellinghoff, Craig Nolan, Igor T. Gavrilovic, Lisa M. DeAngelis, Lauren E. Abrey, Eric C. Holland, Andrew B. Lassman
Longitudinal, leakage corrected and uncorrected rCBV during the first-line treatment of glioblastoma: a prospective study
Eike Steidl, Mathias Müller, Andreas Müller, Ulrich Herrlinger, Elke Hattingen
Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study
M. C. Morisse, N. Etienne-Selloum, D. Bello-Roufai, M. Blonski, L. Taillandier, V. Lorgis, G. Noël, G. Ahle, A. Durán-Peña, M. Boone, B. Chauffert
Correction to: Incidental intracranial meningiomas: a systematic review and meta-analysis of prognostic factors and outcomes
Abdurrahman I. Islim, Midhun Mohan, Richard D. C. Moon, Nisaharan Srikandarajah, Samantha J. Mills, Andrew R. Brodbelt, Michael D. Jenkinson
Retraction Note to: Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis
Yoshihiro Sato, Yoshiaki Honda, Takeshi Asoh, Kotaro Oizumi, Yuki Ohshima, Eiichiro Honda